Answers are grounded in this paper and cite their sources.
Demonstrates enhanced electrochemiluminescence in nanoclusters, indicating breakthrough potential for high-performance sensing applications.
Achieving high-efficiency electrochemiluminescence (ECL) with an ultralong lifetime and a large Stokes shift in a single emitter is highly desirable yet challenging. Herein, we report the supramolecular assembly of gold nanoclusters (Au NCs) protected by a custom-designed ligand, 1-(4-carboxyphenyl)-5-mercapto-1 H -tetrazole (CPMT), which achieved the aforementioned outstanding performance. The CPMT ligand not only stabilized the Au NCs through bidentate Au–S/Au–N coordination, but also induced supramolecular assembly via intermolecular π–π interactions and hydrogen bonding. The obtained self-assembled CPMT-Au NCs exhibited an exceptionally long ECL lifetime of 60.48 μs, since their rigid spherical superstructure effectively minimized interfacial nonradiative decay, leading to an intrinsically prolonged excited-state lifetime, and passivated the emissive cores against oxygen quenching, preserving the long-lived emission under ambient conditions. Concurrently, the assembly showcased a remarkably large Stokes shift of 490 nm, which virtually eliminated self-absorption even in the solid state. The assembled CPMT-Au NCs displayed dramatically enhanced ECL efficiency of 353.37%, a 15-fold enhancement over their nonassembled counterparts, attributable to the synergistic suppression of interfacial energy dissipation and self-absorption as well as the improved electrochemical excitation. Additionally, a sensitive sensing platform for carboxylesterase (CE) activity related to early hepatocellular carcinoma was developed with a detection limit of 1.98 × 10 –7 U/L. Therefore, this work establishes supramolecular assembly driven by ligand engineering as a rational platform for regulating the excited-state properties of metal nanoclusters, opening new avenues for high-performance ECL emitters in lifetime-based sensing, high-brightness devices, and multiplexed bioassays.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: